Yayın:
Impact of Genetic Factors (<i><scp>CYP2C9</scp></i>,<i><scp>VKORC1</scp></i> and <i><scp>CYP4F2</scp></i>) on Warfarin Dose Requirement in the Turkish Population

Sadeleştirilmiş öğe sayfası
dc.contributor.authorHızel, Candan
dc.contributor.authorYeliz Demirci
dc.contributor.authorCandan Hızel
dc.contributor.authorSabit Sarıkaya
dc.contributor.authorİskender Karaltı
dc.contributor.authorÇiğdem Kaspar
dc.contributor.authorSerdar Alpan
dc.contributor.authorE. Genç
dc.contributor.orcid0000-0003-4996-8920
dc.contributor.orcid0000-0002-8921-3584
dc.contributor.orcid0000-0002-9788-1101
dc.date.accessioned2025-11-13T09:59:02Z
dc.date.issued2012-12-06
dc.identifier.doihttps://doi.org/10.1111/bcpt.12024
dc.identifier.endpage214
dc.identifier.issn1742-7835
dc.identifier.issue3
dc.identifier.openalexW2078131078
dc.identifier.startpage209
dc.identifier.urihttps://hdl.handle.net/11421/2801
dc.identifier.urihttps://doi.org/10.1111/bcpt.12024
dc.identifier.volume112
dc.language.isoen
dc.relation.ispartofBasic & Clinical Pharmacology & Toxicology
dc.rightsopenAccess
dc.subjectVKORC1
dc.subjectWarfarin
dc.subjectCYP2C9
dc.subjectTurkish population
dc.subjectMedicine
dc.subjectMaintenance dose
dc.subjectPopulation
dc.subjectInternal medicine
dc.subjectVitamin K epoxide reductase
dc.subjectGenotype
dc.subjectBiology
dc.subjectGenetics
dc.subjectAtrial fibrillation
dc.subjectEnvironmental health
dc.subjectGene
dc.subject.sdg3
dc.titleImpact of Genetic Factors (<i><scp>CYP2C9</scp></i>,<i><scp>VKORC1</scp></i> and <i><scp>CYP4F2</scp></i>) on Warfarin Dose Requirement in the Turkish Population
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5028665996

Dosyalar

Koleksiyonlar

Publications